367 related articles for article (PubMed ID: 6835460)
41. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
42. Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients.
Sjøland JA; Smith Pedersen R; Jespersen J; Gram J
Nephrol Dial Transplant; 2004 May; 19(5):1264-8. PubMed ID: 14993509
[TBL] [Abstract][Full Text] [Related]
43. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.
Heimbürger O; Waniewski J; Werynski A; Tranaeus A; Lindholm B
Kidney Int; 1990 Sep; 38(3):495-506. PubMed ID: 2232493
[TBL] [Abstract][Full Text] [Related]
44. Effect of self-administered intraperitoneal bemiparin on peritoneal transport and ultrafiltration capacity in peritoneal dialysis patients with membrane dysfunction. A randomized, multi-centre open clinical trial.
Del Peso G; Bajo MA; Fontán MP; Martínez J; Marrón B; Selgas R;
Nephrol Dial Transplant; 2012 May; 27(5):2051-8. PubMed ID: 21993377
[TBL] [Abstract][Full Text] [Related]
45. Preserved peritoneal function by short-term two-day peritoneal rest in hemodialysis combination therapy patients.
Ueda A; Nagai K; Yamagata K
J Artif Organs; 2021 Jun; 24(2):296-300. PubMed ID: 33011888
[TBL] [Abstract][Full Text] [Related]
46. Investigation and management of ultrafiltration failure in CAPD.
Mactier RA
Adv Perit Dial; 1991; 7():57-62. PubMed ID: 1680458
[TBL] [Abstract][Full Text] [Related]
47. Localization of imidazolone in the peritoneum of capd patients: a factor for a loss of ultrafiltration.
Nakamura S; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Niwa T
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S107-10. PubMed ID: 11576933
[TBL] [Abstract][Full Text] [Related]
48. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis E
Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
[TBL] [Abstract][Full Text] [Related]
49. [Prognosis and changes of peritoneal function in CAPD and APD patients].
Yokoyama K
Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):259-70. PubMed ID: 8196223
[TBL] [Abstract][Full Text] [Related]
50. Peritoneum: a noble membrane in long-term dialysis treatment.
Barone RJ; Campora MI; Gimenez NS; Ramirez L; Santopietro M; Grbavac D; Pattin M; Panese SA
Adv Perit Dial; 2009; 25():80-4. PubMed ID: 19886323
[TBL] [Abstract][Full Text] [Related]
51. Peritoneal morphology on maintenance dialysis.
Pollock CA; Ibels LS; Eckstein RP; Graham JC; Caterson RJ; Mahony JF; Sheil AG
Am J Nephrol; 1989; 9(3):198-204. PubMed ID: 2667361
[TBL] [Abstract][Full Text] [Related]
52. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
[TBL] [Abstract][Full Text] [Related]
53. Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD.
Selgas R; Paiva A; Bajo MA; Cirugeda A; Aguilera A; Díaz C; Hevia C
Adv Perit Dial; 1998; 14():168-72. PubMed ID: 10649718
[TBL] [Abstract][Full Text] [Related]
54. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.
Davies SJ
Kidney Int; 2004 Dec; 66(6):2437-45. PubMed ID: 15569337
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.
Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
Nephron; 1993; 63(1):32-42. PubMed ID: 8446249
[TBL] [Abstract][Full Text] [Related]
56. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.
Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV
Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847
[TBL] [Abstract][Full Text] [Related]
57. Histologic change of peritoneal membrane in relation to adequacy of dialysis in continuous ambulatory peritoneal dialysis patients.
Savidaki I; Karavias D; Sotsiou F; Alexandri S; Kalliakmani P; Presvelos D; Papachristou E; Goumenos DS; Vlachojannis JG
Perit Dial Int; 2003 Dec; 23 Suppl 2():S26-30. PubMed ID: 17986552
[TBL] [Abstract][Full Text] [Related]
58. CAPD with preservation of ultrafiltration capacity in infants and young children during the first 18 months of treatment.
van Beek R; Schröder CH; de Jong MC; Monnens LA
Helv Paediatr Acta; 1988 Aug; 43(1-2):33-40. PubMed ID: 3170247
[TBL] [Abstract][Full Text] [Related]
59. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis and peritonitis in the short and very long term at risk.
Barone RJ; Cámpora MI; Gimenez NS; Ramirez L; Panese SA; Santopietro M
Adv Perit Dial; 2012; 28():44-9. PubMed ID: 23311212
[TBL] [Abstract][Full Text] [Related]
60. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.
Hauglustaine D; van Meerbeek J; Monballyu J; Goddeeris P; Lauwerijns J; Michielsen P
Clin Nephrol; 1984 Sep; 22(3):158-62. PubMed ID: 6488597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
